Cysticercosis of the central nervous system: How should it be managed?

Hector H. Garcia, Armando Emiliano Gonzalez Zariquiey, Robert H. Gilman

Research output: Contribution to journalReview articlepeer-review

33 Scopus citations

Abstract

Purpose of Review: Taenia solium neurocysticercosis (NCC) has been long recognized as an important cause of neurological morbidity in most of the world. Unwarranted generalization of diagnostic and treatment recommendations made it difficult to assess individual prognosis and responses for each type of NCC. Understanding of the main clinical presentations (dependent on number, location, size, and stage of parasites, as well as on the immune response of the host) allows a better view of treatment options and expected outcomes. Recent Findings: Current treatment options are still limited and involve symptomatic agents, antiparasitic agents, or surgery. The importance of adequate symptomatic management, the potential for improved antiparasitic treatment regimes, in particular combination therapy, and the increasingly important role of minimally invasive neurosurgery are also reviewed in this article. Summary: Treatment decisions in NCC should be individualized in relation to the type of NCC. Initial measures should focus on the symptomatic management before considering antiparasitic therapy when appropriate. Appropriate patient categorization, new antiparasitic regimes, and minimally invasive surgery are improving the prognosis of patients with NCC.

Original languageEnglish
Pages (from-to)423-427
Number of pages5
JournalCurrent Opinion in Infectious Diseases
Volume24
Issue number5
DOIs
StatePublished - Oct 2011
Externally publishedYes

Keywords

  • albendazole
  • cysticercosis
  • praziquantel
  • Taenia solium
  • taeniasis
  • treatment

Fingerprint Dive into the research topics of 'Cysticercosis of the central nervous system: How should it be managed?'. Together they form a unique fingerprint.

Cite this